Duke Cancer Institute

Research Programs

Quick Links

Breadcrumbs Navigation

Home > Clinical Trials > Hope Uronis's Clinical Trials

Jumbo Large Regular Text:

Clinical Trials

Hope Uronis's Clinical Trials

Items 1 - 3 of 3

A Phase II Study of Oxaliplatin, Capecitabine and Bevacizumab in the Treatment of Metastatic Esophagogastric Adenocarciomas
Principal Investigator: Hope Uronis
Phase: Phase II
Phone: 919-668-1861

MAVERICC: A randomized Phase II of Bevacizumab/mFOLFOX6 and Bevacizumab/FOLFIRI with Biomarker Stratification in Patients with Previously Untreated Metastatic Colorectal Cancer
Principal Investigator: Hope Uronis
Phase: Phase II
Phone: 919-668-1861

A Phase 3, Multicenter, Randomized, Double-Blind, Placebo Controlled, Trial of AMG 479 or Placebo in Combination with Gemcitabine as First-line Therapy for Metastatic Adenocarcinoma of the Pancreas (GAMMA)
Principal Investigator: Hope Uronis
Phase: Phase III
Phone: 919-668-1861